Changes of c-fos and c-jun mRNA expression in angiotensin II-induced cardiomyocyte hypertrophy and effects of sodium tanshinone IIA sulfonate

Abstract

The changes of proto-oncogene c-fos and c-jun mRNA expression in angiotensin II (Ang II)-induced hypertrophy and effects of sodium tanshinone IIA sulfonate (STS) in the primary culture of neonatal rat cardiomyocytes were investigated. Twelve neonatal clean grade Wistar rats were selected. The cardiomyocytes were isolated, cultured and divided according to different treatments in the medium. The cardiomyocyte size was determined by phase contrast microscope, and the rate of protein synthesis was measured by [³H]-Leucine incorporation. The c-fos and c-jun mRNA expression in cardiomyocytes was detected by reverse transcription polymerase chain reaction (RT-PCR). It was found after cardiomyocytes were treated with Ang II for 30 min, the c-fos and c-jun mRNA expression in cardiomyocytes was increased significantly (P<0.01). After treatment with Ang II for 24 h, the rate of protein synthesis in Ang II group was significantly increased as compared with control group (P<0.01). After treatment with Ang II for 7 days, the size of cardiomyocytes in Ang II group was increased obviously as compared with control group (P<0.05). After pretreatment with STS or Valsartan before Ang II treatment, both of them could inhibit the above effects of Ang II (P<0.05 or P<0.01). It was suggested that STS could ameliorate Ang II-induced cardiomyocyte hypertrophy by inhibiting c-fos and c-jun mRNA expression and reducing protein synthesis rate of cardiomyocytes.

Keywords

sodium tanshinone IIA sulfonate / angiotensin II / cardiomyocyte hypertrophy / c-fos / c-jun

References

[1] IzumoS., Nadal GinardB., MaholaviV.. Proto-oncogene induced and reprogramming of cardiac gene expression produced by pressure overload. Proc Nati Acad Sci USA, 1988, 85(2): 339-343

[2] SimpsonP. C.. Proto-oncogenes and cardiac hypertrophy. Annu Rev Physiol, 1989, 51: 189-202

[3] ZhanC. Y., TaoX. L., HanS. J., et al.. Effects of tanshinone IIA on the cardiac content of aldosterone and the expression of CYP11B1 and CYP11B2 mRNA related to aldosterone synthesis in spontaneously hypertensive rats. Chin Pharm J (Chinese), 2005, 40(1): 31-34

[4] ZhanC. Y., TaoX. L., TianC., et al.. Expression of intercellular adhesion molecule-1 in the development of hypertrophy and inhibitory effect of tanshinone IIA. Zhong Guo Lin Chuang Kang Fu (Chinese), 2005, 9(19): 254-256

[5] SadoshimaJ., IzumoS.. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: a critical role of the AT₁ receptor subtype. Circ Res, 1993, 73(3): 413-423

[6] WilkinsB. J., MolkentinJ. D.. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophy Res Commun, 2004, 322(4): 1178-1191

[7] MolkentinJ. D.. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Cardiovesc Dis, 2004, 63(3): 467-475

[8] SadoshimaJ., IzumoS.. Signal transduction pathways of angiotensin II-induced c-fos gene expression in cardiac myocytes in vitro. Roles of phospholipid-derived second messengers. Circ Res, 1993, 73(3): 424-438

[9] PatmoreL., WhitingR. L.. Calcium entry blocking properties of sodium tanshinone IIA sulfonate, an active principal of the antianginal extract, Danshen. Br J Pharmacol, 1982, 75(Suppl): 149-152

[10] XuC. Q., WangX. M., FanJ. S., et al.. Effects of Danshentong IIA on the transmembrane potential and L-type Ca²⁺ current in guinea pig ventricular myocytes. Chin J Patho (Chinese), 1997, 13(1): 43-47

[11] XuC. Q., LouY. P., YangB. F., et al.. Relative analysis of inhibiting effect of L-type Ca²⁺ current and shortening effects of action potential duration of Danshentong IIA in guinea pig ventricular myocytes. Chin Pharm Bull (Chinese), 1998, 14(5): 428-431